Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.

Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P, Smith A, Beck S, Pollard SM.

Genes Dev. 2013 Mar 15;27(6):654-69. doi: 10.1101/gad.212662.112.


Reprogramming cancer cells to pluripotency: an experimental tool for exploring cancer epigenetics.

Stricker S, Pollard S.

Epigenetics. 2014 Jun;9(6):798-802. doi: 10.4161/epi.28600. Epub 2014 Mar 31.


Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.


Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.

Natsume A, Ito M, Katsushima K, Ohka F, Hatanaka A, Shinjo K, Sato S, Takahashi S, Ishikawa Y, Takeuchi I, Shimogawa H, Uesugi M, Okano H, Kim SU, Wakabayashi T, Issa JP, Sekido Y, Kondo Y.

Cancer Res. 2013 Jul 15;73(14):4559-70. doi: 10.1158/0008-5472.CAN-13-0109. Epub 2013 May 29.


A microarray-based DNA methylation study of glioblastoma multiforme.

Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, Fernandez AF, Ropero S, Schackert G, Esteller M.

Epigenetics. 2009 May 16;4(4):255-64. Epub 2009 May 29.


Epigenetic setting and reprogramming for neural cell fate determination and differentiation.

Imamura T, Uesaka M, Nakashima K.

Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652). pii: 20130511. doi: 10.1098/rstb.2013.0511. Review.


Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.

Yang CM, Chiba T, Brill B, Delis N, von Manstein V, Vafaizadeh V, Oellerich T, Groner B.

Int J Cancer. 2015 Nov 15;137(10):2296-309. doi: 10.1002/ijc.29606. Epub 2015 Jun 5.


Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.

Farthing CR, Ficz G, Ng RK, Chan CF, Andrews S, Dean W, Hemberger M, Reik W.

PLoS Genet. 2008 Jun 27;4(6):e1000116. doi: 10.1371/journal.pgen.1000116.


Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.

Bai Y, Zhang QG, Wang XH.

Eur J Med Res. 2014 Dec 11;19:66. doi: 10.1186/s40001-014-0066-4.


From the Cover: Neutralization of terminal differentiation in gliomagenesis.

Hu J, Ho AL, Yuan L, Hu B, Hua S, Hwang SS, Zhang J, Hu T, Zheng H, Gan B, Wu G, Wang YA, Chin L, DePinho RA.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14520-7. doi: 10.1073/pnas.1308610110. Epub 2013 Aug 5.


Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma.

Nabilsi NH, Deleyrolle LP, Darst RP, Riva A, Reynolds BA, Kladde MP.

Genome Res. 2014 Feb;24(2):329-39. doi: 10.1101/gr.161737.113. Epub 2013 Oct 8.


BMI1 sustains human glioblastoma multiforme stem cell renewal.

Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G.

J Neurosci. 2009 Jul 15;29(28):8884-96. doi: 10.1523/JNEUROSCI.0968-09.2009.


Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.

Kurscheid S, Bady P, Sciuscio D, Samarzija I, Shay T, Vassallo I, Criekinge WV, Daniel RT, van den Bent MJ, Marosi C, Weller M, Mason WP, Domany E, Stupp R, Delorenzi M, Hegi ME.

Genome Biol. 2015 Jan 27;16:16. doi: 10.1186/s13059-015-0583-7.


Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells.

Nissenbaum J, Bar-Nur O, Ben-David E, Benvenisty N.

Stem Cell Reports. 2013 Dec 12;1(6):509-17. doi: 10.1016/j.stemcr.2013.11.007. eCollection 2013.


Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.

Li Y, Hong N, Zhang A, Chen W, Wang RH, Xu XL, Deng CX.

Cell Death Dis. 2014 Dec 4;5:e1550. doi: 10.1038/cddis.2014.499.


Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.

Menendez JA, Alarcón T, Corominas-Faja B, Cuyàs E, López-Bonet E, Martin AG, Vellon L.

Cell Cycle. 2014;13(3):358-70. doi: 10.4161/cc.27770. Epub 2014 Jan 9.


Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.

He W, Kang X, Du H, Song B, Lu Z, Huang Y, Wang D, Sun X, Yu Y, Fan Y.

PLoS One. 2014 Sep 24;9(9):e108350. doi: 10.1371/journal.pone.0108350. eCollection 2014.


Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.

Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S.

Oncogene. 2011 Aug 4;30(31):3454-67. doi: 10.1038/onc.2011.58. Epub 2011 Mar 7.

Items per page

Supplemental Content

Write to the Help Desk